Breaking News Instant updates and real-time market news.

OESX

Orion Energy

$0.91

0.017 (1.90%)

, AYI

Acuity Brands

$118.75

-0.24 (-0.20%)

15:23
03/25/19
03/25
15:23
03/25/19
15:23

Orion CEO says company has 'a lot of momentum'

In an exclusive interview with The Fly, Orion Energy (OESX) CEO Mike Altschaefl talked about competition and why he believes the company has several "competitive advantages": "It's a competitive industry and the competition comes in a couple of different paths, depending on how we go to market. We go to market in three different ways. First, we have our large national accounts where we sell directly to end users who are working directly with the company that needs to put light fixtures into their facilities in those situations. We tend to be competing with some of the larger players in the industry - names like Acuity (AYI), Eaton lighting (ETN), Hubbell (HUBB) and Cree (CREE). And where we differentiate from theirs is that we believe to be best suited and staffed, and with experience to actually handle the installation of the product versus simply selling the product. The second path to market is through resellers. These would be energy service companies and electrical contractors that we sell to directly and they then sell to their customers. In that area, the competition is more varied. It can be some of the very large competitors, can also be other regional or smaller lighting companies and also fixtures that are being sourced from overseas. Then finally, another path to market is our agent driven distribution market where we are represented by lighting agencies across the U.S. We have approximately 50 manufacturer sales reps that represent our product to distributors, for selling to electrical contractors. And in that market, we again are competing against the larger players - maybe some of the medium sized players - but also a little more significantly against some of the foreign sourced product, primarily coming from Asia. In all of those, we kind of view our product quality and our timeliness of delivery, our U.S. based manufacturing capabilities as the competitive advantages that we can bring to the potential customers. We've not given public estimates of our future revenues for fiscal 2020, but we feel we've got a lot of momentum, and we're pretty optimistic with a larger customer account so we can continue a nice growth path as we go forward in this industry." "Meet the Company" is The Fly's recurring series of exclusive short interviews with Executive Officers to offer a deeper look inside the company.

OESX

Orion Energy

$0.91

0.017 (1.90%)

AYI

Acuity Brands

$118.75

-0.24 (-0.20%)

ETN

Eaton

$79.06

0.08 (0.10%)

HUBB

Hubbell

$114.97

0.125 (0.11%)

CREE

Cree

$56.09

-0.42 (-0.74%)

  • 28

    Mar

  • 03

    Apr

  • 01

    May

OESX Orion Energy
$0.91

0.017 (1.90%)

11/13/18
ROTH
11/13/18
NO CHANGE
Target $0.85
ROTH
Neutral
Orion Energy price target lowered to 85c from $1.00 at Roth Capital
Roth Capital analyst Craig Irwin lowered his price target for Orion Energy to 85c from $1.00 saying the company reported "weak" Q2 revenue, with earnings inline on tight cost controls. The analyst, who awaits improved visibility on revenue growth before potentially becoming constructive on the stock, keeps a Neutral rating on Orion Energy.
AYI Acuity Brands
$118.75

-0.24 (-0.20%)

03/20/19
GSCO
03/20/19
UPGRADE
GSCO
Neutral
Acuity Brands upgraded to Neutral from Sell at Goldman Sachs
03/06/19
03/06/19
UPGRADE
Target $148

Outperform
Acuity Brands upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst John Walsh upgraded Acuity Brands to Outperform from Neutral as he believes lighting fundamentals are improving, against tempered expectations, and sees CS-defined EBITDA growth inflecting positive in H2 CY19. Further, peers point to pricing momentum which helps improve gross margin performance, he contends. The analyst also raised his price target on the shares to $148 from $128.
03/06/19
FBCO
03/06/19
UPGRADE
FBCO
Outperform
Acuity Brands upgraded to Outperform from Neutral at Credit Suisse
03/21/19
GSCO
03/21/19
UPGRADE
Target $121
GSCO
Neutral
Goldman upgrades Acuity Brands to Neutral on balanced risk/reward
Goldman Sachs analyst Brian Lee last night upgraded Acuity Brands to Neutral from Sell with an unchanged price target of $121. With the stock down 22% since his downgrade to Sell on September 11, 2018, the analyst now sees a more balanced risk/reward at current valuation levels. Further, downside risk to consensus estimates in fiscal 2019 and 2020 is limited, Lee tells investors in a research note.
ETN Eaton
$79.06

0.08 (0.10%)

03/12/19
KEYB
03/12/19
UPGRADE
Target $93
KEYB
Overweight
Eaton upgraded to Overweight given 'unwarranted discount' at KeyBanc
As previously reported, KeyBanc analyst Jeffrey Hammond upgraded Eaton to Overweight from Sector Weight, with a $93 price target, as he believes the stock has traded at an "unwarranted discount" to peers. Regarding the company's portfolio action, given the fragmented nature of the lighting market and Eaton's leading competitive position therein, the analyst expects a number of logical suitors to emerge, rendering a sale, rather than a tax-free spin, as the likeliest transactional outcome for Lighting. More broadly, given the company's attractive late-cycle mix coupled with a renewed emphasis on organic growth, and enhanced free cash flow optionality, he believes Eaton is uniquely positioned to both thrive in a healthy fundamental environment and weather the storm should a recession ensue.
03/12/19
03/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. American Electric (AEP) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Turnure saying the company has filled out $1.4B of non-utility renewables investment and entered into an Oklahoma settlement that "bodes well for lag catch up" over the last two months. 2. Lloyds Banking (LYG) upgraded to Neutral from Sell at Goldman Sachs. 3. RedHill Biopharma (RDHL) upgraded to Buy from Hold at WBB Securities. 4. Eaton (ETN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Jeffrey Hammond saying he believes the stock has traded at an "unwarranted discount" to peers. 5. Ranger Energy (RNGR) upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/04/19
VERT
03/04/19
UPGRADE
VERT
Buy
Eaton upgraded to Buy from Hold at Vertical Research
03/12/19
KEYB
03/12/19
UPGRADE
KEYB
Overweight
Eaton upgraded to Overweight from Sector Weight at KeyBanc
HUBB Hubbell
$114.97

0.125 (0.11%)

12/18/18
12/18/18
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Philip Morris (PM) downgraded to Underperform from Neutral at Credit Suisse with analyst Alan Erskine saying after conducting a survey of next-generation products users in Japan, the U.S. and the U.K., he believes slower progress in the take-up of heated tobacco products and weaker combustible organic growth will challenge the high-single-digit earnings growth models of Philip Morris and British American Tobacco (BTI). 2. Wabco (WBC) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Courtney Yakavonis saying she is losing conviction that Wabco can return to its "normal" margin and outgrowth framework in FY19, citing rolling global truck markets, recent underperformance in core outgrowth, and sustained margin risks as limiting factors to the previously premium multiple. 3. Kansas City Southern (KSU) and Schneider National (SNDR) were downgraded to Neutral from Overweight at JPMorgan. 4. Illinois Tool Works (ITW) and Flowserve (FLS) were downgraded to Underweight from Equal Weight at Morgan Stanley, while Hubbell (HUBB) was downgraded to Equal Weight from Overweight at Morgan Stanley. 5. Worldpay (WP) downgraded to Outperform from Top Pick at RBC Capital with analyst Daniel Perlin saying while the company trades in line with its peers on a relative price-to-earnings basis, its shares remain attractive given the "conservative" expectations for synergy targets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/07/19
JPMS
01/07/19
NO CHANGE
Target $140
JPMS
Overweight
Hubbell shares 'too cheap' given 'solid' fundamentals, says JPMorgan
JPMorgan analyst Stephen Tusa views Hubbell shares as "too cheap" in the context of the company's "solid fundamentals." The analyst lowered his price target for the shares to $140 from $148 and keeps an Overweight rating on the name. Hubbell screens as an attractive relative value at a 15% enterprise value to free cash flow discount to the group, after negative earnings revisions mainly on the back of tariff concerns, Tusa tells investors in a research note. He thinks tariff related risks are now more fully embedded in Hubbell's multiple.
01/08/19
OPCO
01/08/19
DOWNGRADE
OPCO
Perform
Hubbell downgraded to Perform from Outperform at Oppenheimer
01/08/19
OPCO
01/08/19
DOWNGRADE
OPCO
Perform
Hubbell downgraded to Perform at Oppenheimer
As previously reported, Oppenheimer analyst Christopher Glynn downgraded Hubbell to Perform from Outperform due to relative devaluation of the group as material context for low headline multiples, against his view that the portfolios lack cyclical or strategic differentiation against the current backdrop. The analyst notes that the company's multiple has contracted 35% TTM, worse than the 26% for the group, as the Aclara acquisition added about $1B in debt and given extinguished historical expectations that Hubbell was a takeout candidate.
CREE Cree
$56.09

-0.42 (-0.74%)

03/20/19
JMPS
03/20/19
UPGRADE
JMPS
Outperform
Cree upgraded to Outperform from Market Perform at JMP Securities
03/20/19
03/20/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Texas Roadhouse (TXRH) upgraded to Overweight from Equal Weight at Stephens with analyst Will Slabaugh saying he thinks the company can deliver better than expected same-store sales and EPS growth as it implements a price increase at the beginning of Q2. 2. Cree (CREE) upgraded to Outperform from Market Perform at JMP Securities with analyst Joseph Osha stating he believes that he has been too conservative on the valuation front given his view that Cree "is positioned squarely at the center of some of the most interesting developments in the electronics business." 3. Nevro (NVRO) upgraded to Outperform from Market Perform at Wells Fargo with analyst Lawrence Biegelsen noting that incoming CEO Keith Grossman has successfully turned around the previous two companies he led and saying he is "highly confident" he will be successful in turning around Nevro. 4. Dollar Tree (DLTR) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Joseph Feldman saying meetings with management gave him increased visibility and confidence in the company's plan and he believes Dollar Tree should see a return to earnings growth in the second half of 2019. 5. Whiting Petroleum (WLL) upgraded to Overweight from Equalweight at Capital One citing an increased oil price deck. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
JMPS
03/20/19
UPGRADE
Target $74
JMPS
Outperform
Cree upgraded to Outperform after industry conference at JMP Securities
As previously reported, JMP Securities analyst Joseph Osha upgraded Cree to Outperform from Market Perform after attending the Applied Power Electronics Conference, which he said underscored the extent to which wide bandgap materials are becoming the default solution in high-voltage power electronics. After attending the APEC event and meeting with a senior CREE executive along with the CTO of the PowerAmerica consortium, the analyst now thinks that he has been too conservative on the valuation front given his view that Cree "is positioned squarely at the center of some of the most interesting developments in the electronics business." Osha, who also cites the fact that the company's troubled lighting business is being sold, has a $74 price target on Cree shares.
01/31/19
OPCO
01/31/19
NO CHANGE
Target $59
OPCO
Outperform
Cree price target raised to $59 from $53 at Oppenheimer
Oppenheimer analyst Colin Rusch raised his price target for Cree to $59 from $53 as he sees lower risk to 2020 estimates due to strong SiC demand and improved operational performance. The analyst believes Cree remains supply constrained through at least 2020 for its SiC materials even as it doubles capacity, continues to see significant growth in EV demand, particularly in China, and believes the U.S. and EU will hit tipping points for growth in 2021 and 2022. Rusch reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

17:19
12/13/19
12/13
17:19
12/13/19
17:19
Hot Stocks
Live Nation, Zebra Technologies, Steris to move to S&P 500 at open on 12/23 »

Live Nation (LYV), Zebra…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BAESY

BAE Systems

$0.00

(0.00%)

17:15
12/13/19
12/13
17:15
12/13/19
17:15
Hot Stocks
BAE Systems awarded $249.15M Army contract modification »

BAE Systems was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$146.32

-0.14 (-0.10%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Hot Stocks
West Pharmaceutical announces 848K share repurchase authorization »

On December 10, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:02
12/13/19
12/13
17:02
12/13/19
17:02
Earnings
Amarin sees FY20 revenue $650M-$700M, consensus $654.55M »

With respect to 2020,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

IBIO

iBio

$0.22

-0.0179 (-7.43%)

17:01
12/13/19
12/13
17:01
12/13/19
17:01
Hot Stocks
iBio receives NYSE noncompliance notice »

iBio, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APLT

Applied Therapeutics

$21.23

0.29 (1.38%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Syndicate
Breaking Syndicate news story on Applied Therapeutics »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:59
12/13/19
12/13
16:59
12/13/19
16:59
Earnings
Amarin raises FY19 revenue view to $410M-$425M from $380M-$420M 

FY19 consensus $410.25M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BIO

Bio-Rad

$354.69

-8.005 (-2.21%)

16:56
12/13/19
12/13
16:56
12/13/19
16:56
Hot Stocks
Bio-Rad progressing from ransomware attack recovery detected on Dec 5th »

Bio-Rad Laboratories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

16:50
12/13/19
12/13
16:50
12/13/19
16:50
Hot Stocks
Amarin confirms FDA approval of Vascepa »

Amarin announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.